Intriguingly, alkaloids 1 and 2 represent novel alkaloids within the ibogan-type MIAs category, and 1–3 possess potential against AD by inhibiting Aβ production and tau phosphorylation in cellular models. The gene discussed is MAPT; the disease is Alzheimer disease.